Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2003
07/10/2003US20030129261 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
07/10/2003US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier
07/10/2003US20030129233 Sustained release hydrophobic bioactive PLGA microspheres
07/10/2003US20030129216 A kit containing the enzyme lipoprotein lipase in a stabilized form in a container and a topical formulation of monoglycerides, diglycerides or triglycerides of synthetic, plant or animal origin for application to human skin
07/10/2003US20030129205 Inducing presensitization of immune system towards an immunogen carrying lymphocytes epitope homologous to allergen; immunosuppressants
07/10/2003US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
07/10/2003US20030129198 Methods to produce high levels of C. difficile toxins
07/10/2003US20030129196 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
07/10/2003US20030129195 Use of heat shock proteins
07/10/2003US20030129193 Comprises antibody-coagulant constructs (coaguligands) for induction of (drug resistant) tumor thrombosis/necrosis
07/10/2003US20030129192 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/10/2003US20030129189 Angiogenesis inhibitors for treament of inflammation, cachexia, septic shock, cerebral malaria, arthritis, and graft-rejection
07/10/2003US20030129185 Chimeric antibodies; lymphocytes; genetic engineering; for treatment of myeloma
07/10/2003US20030129184 Monoclonal antibody specific to polypeptide which induces interferon-gamma production
07/10/2003US20030129183 Hemostatic compositions, devices and methods
07/10/2003US20030129182 Contacting vitreous humor with beta-glucuronidase, matrix metalloproteinase, chondroitinase, chondroitin sulfatase, and/or protein kinase; thimerosal-free
07/10/2003US20030129181 Hydrolases modified by polyoxyethylene glycol for induction of high plasmatic levels of free tumor necrosis factor
07/10/2003US20030129180 Athletes foot; skin disorders; using enzyme
07/10/2003US20030129179 Memory enhancing protein
07/10/2003US20030129178 Reduction of adipose tissue
07/10/2003US20030129177 Mixture of carnitine compound, coenzyme Q10, nicotinamide, riboflavin and pantothenic acid; cardiovascular disorders
07/10/2003US20030129176 Atherosclerosis-associated genes
07/10/2003US20030129175 Gene therapy; heterogeneity tissue transcription; antitumor agents
07/10/2003US20030129172 Animal growth regulator
07/10/2003US20030129170 Central nervous system disorders; antidiabetic agents
07/10/2003US20030129168 Expression of proteins for treating asthma via ligand mediated activation of their encoding genes
07/10/2003US20030129164 Expression of glial-derived neurotrophic factor for treatment of diseases of the eye
07/10/2003US20030129162 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
07/10/2003US20030129161 Interleukin-12 as a veterinary vaccine adjuvant
07/10/2003US20030129160 Obesity therapy; adjusting interleukin concentration
07/10/2003US20030129159 Derivatisation of proteins
07/10/2003US20030129156 Use of a polypeptide for treatment of pruritis in animals
07/10/2003US20030129147 Use of bacterial phage associated lysing proteins for treating bacterial dental caries
07/10/2003US20030129146 Genetic engineered protein
07/10/2003US20030129141 Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery
07/10/2003US20030129079 Method for protein-preserving purification of contaminated biological liquids
07/10/2003CA2473728A1 Methods of modulating heme oxygenase-1 expression and treating heme oxygenase-1 mediated conditions
07/10/2003CA2472121A1 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof
07/10/2003CA2471924A1 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
07/10/2003CA2471916A1 Modified bacterial surface layer proteins
07/10/2003CA2471540A1 A method for the establishment of a pluripotent human blastocyst-derived stem cell line
07/10/2003CA2471531A1 Agents for treating mild cognitive impairment
07/10/2003CA2471388A1 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471297A1 Human netrin receptor and uses thereof
07/10/2003CA2471130A1 Il-17 like molecules and uses thereof
07/10/2003CA2471127A1 An antisense strategy to modulate estrogen receptor response (er.alpha. and/or er.beta.)
07/10/2003CA2471119A1 Lipase genes and proteins
07/10/2003CA2470903A1 A system for stable expression of sirnas in mammalian cells
07/10/2003CA2470781A1 Cystine-knot fold protein
07/10/2003CA2470696A1 Pecam-1 modulation
07/10/2003CA2470684A1 A haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2470511A1 Liquid composition of factor vii polypeptides
07/10/2003CA2470367A1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
07/10/2003CA2470313A1 Liquid composition of modified factor vii polypeptides
07/10/2003CA2469690A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003CA2468619A1 Adiponectin fragments and conjugates
07/10/2003CA2468081A1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
07/10/2003CA2463738A1 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
07/10/2003CA2463143A1 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
07/10/2003CA2458751A1 Compositions and methods for the treatement of immune related diseases
07/09/2003EP1325932A2 Anti-vegf antibodies
07/09/2003EP1325931A1 Inhibitors of human neutrophil elastase
07/09/2003EP1325930A1 Mammal prolactin variants
07/09/2003EP1325929A2 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants
07/09/2003EP1325751A1 Novel drugs for liver diseases
07/09/2003EP1325324A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin
07/09/2003EP1325150A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
07/09/2003EP1325149A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
07/09/2003EP1325147A2 Industrial-scale serum-free production of recombinant factor vii in mammalian cells
07/09/2003EP1325145A1 Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts
07/09/2003EP1325139A1 Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals
07/09/2003EP1325133A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus
07/09/2003EP1325131A2 A human-protein coupled receptor, hgprbmy6, expressed highly in small intestine
07/09/2003EP1325130A2 Nogo receptor homologs
07/09/2003EP1325129A2 Identification of a new cytotoxic activity from the ink of aplysia punctata
07/09/2003EP1325128A2 Lipocalins
07/09/2003EP1325127A2 Method for the production of vitamin k-dependent proteins
07/09/2003EP1325126A2 Human ion-exchanger proteins and polynucleotides encoding the same
07/09/2003EP1325125A2 Chromosome 3p21.3 genes are tumor suppressors
07/09/2003EP1325123A1 Inhibition of stenosis or restenosis by p-selectin antagonists
07/09/2003EP1325122A2 Modulation of the transcription of pro-inflammatory gene products
07/09/2003EP1325121A2 Antisense oligonucleotide directed toward mammalian vegf receptor genes and uses thereof
07/09/2003EP1325117A2 Lipid metabolism enzymes
07/09/2003EP1325116A2 Isoprenoid-dependent ras anchorage (idra) proteins
07/09/2003EP1325113A2 Factor vii glycoforms
07/09/2003EP1325112A2 Methods of isolating bipotent hepatic progenitor cells
07/09/2003EP1325035A1 Starch
07/09/2003EP1325034A1 Pharmaceutically acceptable starch
07/09/2003EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof
07/09/2003EP1325031A2 Use of anti-human integrin alpha d antibodies to treat spinal cord injury
07/09/2003EP1325030A2 Genes isolated from dendritic cells, gene products and methods employing the same
07/09/2003EP1325028A2 New inhibitors of iapp fibril formation and uses thereof
07/09/2003EP1325026A2 Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use
07/09/2003EP1325025A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells
07/09/2003EP1325020A1 21 human secreted proteins
07/09/2003EP1325019A1 Antisense modulation of clusterin expression
07/09/2003EP1325018A1 Antisense modulation of her-2 expression
07/09/2003EP1324997A2 Dioxolane analogs for improved inter-cellular delivery
1 ... 1814 1815 1816 1817 1818 1819 1820 1821 1822 1823 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 1834 ... 3163